Noticias de dinero

Bristol Myers Squibb (BMY) Q4 earnings report 2023

Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth.  Here’s what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv: Earnings per share: $1.70

READ MORE
Noticias de dinero

J&J, Merck and Bristol Myers Squibb in the hot seat

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks

READ MORE
Global

Commanders hire ex-Warriors general manager Bob Myers as adviser

Josh Harris and his investment partners coughed up $6.05 billion to purchase the Washington Commanders last summer. The purchase price was a record for a North American sports franchise and the sale was approved by a unanimous vote of NFL owners desperate to rid their exclusive fraternity of the villainous Dan Snyder. Harris stayed in

READ MORE
Noticias de dinero

Bristol Myers Squibb to buy Karuna Therapeutics

The New York Stock Exchange welcomes Bristol Myers Squibb on Nov. 20th, 2020. NYSE Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock popped more than 47% on the news Friday morning, hitting around $317 a share. Bristol Myers

READ MORE
Noticias de dinero

Bristol Myers Squibb (BMY) Q3 earnings report 2023

Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition.  Bristol Myers, one of the world’s largest pharmaceutical companies, raked in $10.96 billion in revenue for the third quarter, down

READ MORE